Shalini Sharp - Insider Trading & Ownership

Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Shalini Sharp is at least $6M dollars as of June 20, 2025. Shalini Sharp is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $4.69M. Shalini Sharp is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $680K. Shalini Sharp is the Director of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $633K.
Signature
/s/ Jeffrey Finer, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Shalini Sharp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. Director $4.69M May 21, 2025
NBIX NEUROCRINE BIOSCIENCES INC Director $680K May 21, 2025
OGN Organon & Co. Director $633K Jun 13, 2025
MRTX Mirati Therapeutics, Inc. Director Jan 23, 2024
DTIL PRECISION BIOSCIENCES INC Director May 10, 2021
SEPN Septerna, Inc. Director Jun 17, 2025
STRO SUTRO BIOPHARMA, INC. Director Jun 6, 2022

Insider Transactions Reported by Shalini Sharp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.